Evaluation of adenine as scaffold for the development of novel P2X3 receptor antagonists.
Eur J Med Chem
; 65: 41-50, 2013 Jul.
Article
en En
| MEDLINE
| ID: mdl-23688699
Palabras clave
2',3'-O-(2,4,6-trinitrophenyl)-ATP; ATP; Adenine derivatives; CPU; DCM; DRG; HTS; Hill coefficient; MOE; Molecular Operating Environment; NOE; P2X3 receptor; P2X3 receptor antagonists; PPADS; PPP; PTLC; PTSA; Patch clamp; Purine; Purine derivatives; Purinergic receptors; TBAN; TEA; TFAA; TG; TLC; TNP-ATP; central processing unit; dichloromethane; dorsal root ganglion; high-throughput screening; n(H); nuclear Overhauser effect; p-toluenesulfonic acid; preparative thin-layer chromatography; pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid; rise time; tetrabutylammonium nitrate; thin-layer chromatography; time constant of desensitization decay; triethylamine; trifluoroacetic anhydride; trigeminal ganglia; triphosphate; α,ß-meATP; α,ß-methyleneATP; τ(des1;2); τ(on)
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Adenina
/
Receptores Purinérgicos P2X3
Límite:
Animals
/
Humans
Idioma:
En
Revista:
Eur J Med Chem
Año:
2013
Tipo del documento:
Article
País de afiliación:
Italia